Compare BMI & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BMI | TMDX |
|---|---|---|
| Founded | 1905 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 4.6B |
| IPO Year | 1994 | 2019 |
| Metric | BMI | TMDX |
|---|---|---|
| Price | $147.46 | $123.82 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 9 |
| Target Price | ★ $193.14 | $154.00 |
| AVG Volume (30 Days) | 286.5K | ★ 773.0K |
| Earning Date | 04-29-2026 | 06-01-2026 |
| Dividend Yield | ★ 1.06% | N/A |
| EPS Growth | 13.24 | ★ 382.18 |
| EPS | 4.79 | ★ 4.87 |
| Revenue | N/A | ★ $605,494,000.00 |
| Revenue This Year | $6.52 | $24.12 |
| Revenue Next Year | $6.82 | $18.69 |
| P/E Ratio | $31.60 | ★ $26.03 |
| Revenue Growth | N/A | ★ 37.13 |
| 52 Week Low | $139.14 | $62.42 |
| 52 Week High | $256.08 | $156.00 |
| Indicator | BMI | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 42.92 | 40.73 |
| Support Level | $139.14 | $123.37 |
| Resistance Level | $184.62 | $131.86 |
| Average True Range (ATR) | 5.48 | 7.79 |
| MACD | 0.19 | -1.86 |
| Stochastic Oscillator | 27.55 | 12.11 |
Badger Meter is a provider of water management solutions. The company's solutions encompass measurement and control hardware, connectivity and communication, data visualization and software. Badger Meter has globalised operations, with the vast majority of revenue derived from the USA. The company is an innovator in flow measurement, water quality and control products, serving water utilities, municipalities and commercial and industrial customers world-wide.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.